ABTA PARTNERS WITH THE FDA AND BRAIN TUMOR COMMUNITY TO EVALUATE AND ADVANCE CLINICAL DEVELOPMENT OF BRAIN METASTASES TREATMENTS
Approximately 200,000 cancer patients are diagnosed with brain metastases every year. And yet, the treatment and care paradigm to combat brain metastases has remained relatively unchanged. To better understand the needs of patients diagnosed with metastatic brain tumors, the American Brain Tumor Association has launched the Metastatic Brain Tumor Initiative to help address the unmet needs of this patient community.
PAUL MCDOWELL: DOING THE THINGS YOU LOVE IS GOOD THERAPY
It has been 23 years since Paul McDowell had his last treatment for two brain tumors, including a diagnosis of a glioblastoma. An inspiring journey from a poor prognosis to a 23-year survivorship, Paul is living for today by mentoring patients to live for tomorrow.
LEARN ABOUT THE LATEST BRAIN TUMOR TREATMENT ADVANCEMENTS ALONGSIDE PATIENTS AND CAREGIVERS FROM ACROSS THE U.S.; ATTEND THE ABTA NATIONAL CONFERENCE
Taking place in Chicago, Ill. on September 6-7, hundreds of patients and caregivers will come together to learn about the latest diagnostic and medical advancements.
ABTA REPORTS THE LATEST BRAIN CANCER RESEARCH FROM THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING
Earlier this month, the American Brain Tumor Association attended the American Association for Cancer Research 2019 Annual Meeting. Read on to learn about emerging brain tumor research, and the scientists behind the latest advances.
Upcoming Events
 |
 |
|
| May 4, 2019 BT5K Run & Walk Denver Denver, CO |
May 4, 2019 Robertson Racing for One Lap America South Bend, IN |
May 11, 2019 BT5K Run & Walk Michigan Milford, MI |
| LEARN MORE | LEARN MORE | LEARN MORE |